AstraZeneca may sell some of its medicines directly to patients in the US, according to Chief Executive Officer Pascal Soriot. AstraZeneca is looking to the US for growth, with Soriot saying the company will be self-sufficient in the US in a couple of months. He speaks with Bloomberg's Carol Massar, Tim Stenovec, and Madison Muller

FCA's Walls Talks UK Deregulation, 'Golden Age' For The City
07:37

IDA Ireland's Michael Lohan Talks Tariff Threats
07:46

Rep. Katherine Clark Talks ICE in Minnesota
09:16